Skip to main content
WWP IMPACT IN ACTION: your support can make a life-changing difference for warriors and their families. LEARN MORE >
Contact Us Español
Latest News
Sep 16, 2022

Wounded Warrior Project® (WWP) announced today the elections of Kristen Robinson Darcy, chief operating officer (COO) and head of services and operations of Fidelity Charitable®, and Jeff...

Sep 15, 2022

Almost 50 Wounded Veterans Meet with U.S. Senators, Representatives, and Congressional Staff WASHINGTON, Sept. 15, 2022 /PRNewswire/ -- Wounded Warrior Project® (WWP) this week brought dozens of...

Sep 1, 2022

Too many veterans are still dying by suicide. To address this issue, Wounded Warrior Project® (WWP) is working to reduce the fears and barriers warriors face when asking for help. "The warriors...

Wounded Warrior Project: Blood Tests to Treat PTSD

WASHINGTON, Feb. 21, 2018 /PRNewswire-USNewswire/ -- It is estimated 500,000 of this generation of wounded veterans live with the symptoms of post-traumatic stress disorder (PTSD). Another 320,000 suffered a traumatic brain injury (TBI). There are few proven methods to diagnose and treat the signature wounds of the wars in Afghanistan and Iraq. Not every veteran living with these ailments responds the same to specific treatment.

Wounded Warrior Project VP of Mental Health Programs and Independence Services Michael Richardson joined Cohen Veterans Bioscience CEO and President Dr. Magali Haas to announce blood tests to better target treatment for PTSD and TBI.

To help, Wounded Warrior Project® (WWP) is working with Cohen Veterans Bioscience (CVB) to identify and study biomarkers that could improve treatment options. A biomarker is a measurable substance indicative of a disease or infection. For veterans, a specific biomarker found in a blood sample can confirm a PTSD diagnosis and the potential to respond to treatment.

By studying these substances, researchers hope to better target PTSD treatment in veterans and other trauma survivors.

"We would love to cure PTSD and TBI one day," said Mike Richardson, WWP vice president of mental health and independence services. "Until then, we will continue to target treatment and do what is best for the veterans we serve."

As part of this support Wounded Warrior Project's Warrior Care Network® will be actively involved in the research into biomarkers – testing wounded veterans and helping identify the most effective treatment options. Warrior Care Network is an innovative partnership with four top facilities focused on providing world-class mental health care to wounded veterans. While the treatment shows clinically proven results, more can still be done.

"We value Wounded Warrior Project's collaboration and support to help advance a first generation of PTSD & TBI diagnostics," said Magali Haas, MD, PhD, CVB's CEO & President.  "We need an all-hands approach to tackle this important scientific & clinical challenge."

This collaboration can advance a roadmap for discovery, replication, and qualification of biomarkers – an effort that can create solutions in years, not decades.

About Wounded Warrior Project
Wounded Warrior Project® (WWP) connects, serves, and empowers wounded warriors. Read more here.

About Cohen Veterans Bioscience 
Cohen Veterans Bioscience is a national, nonpartisan research organization dedicated to fast-tracking the development of diagnostic tests and personalized therapeutics for the millions of veterans and civilians who suffer the devastating effects of trauma-related and other brain disorders. To support & learn more about our research efforts, visit their website.

 

SOURCE Wounded Warrior Project

For further information: Rob Louis - Public Relations, Email: rlouis@woundedwarriorproject.org, Phone: 904.627.0432 or Victoria Fort - Public Relations, press@cohenbioscience.org, 202.361.0445

Here are Wounded Warriors Social Links, if you want to share this page content on social media then select the media you would like to share to from the list below